“…The addition of L-Ara4N to lipid A has been shown to confer on Gram-negative bacteria resistance to several cationic antimicrobial peptides (CAMPs), including polymyxin B (PMB), a peptide antibiotic often used to study antimicrobial peptide resistance (19,20,37,38,40,63,67,74). The lipid A modifications, controlled through the BasRS (PmrAB) TCRS, in both E. coli and Salmonella spp.…”